CSS is committed to the active development of tariff structures (in particular TARMED / TARDOC, SwissDRG, LOA, physiotherapy). It espouses the primacy of the criterion of 'appropriateness' and advocates a strict separation of structure and price. The tariff structures must reflect current medical knowledge, enable services to be provided cost effectively and take changing healthcare structures into consideration. However, it rejects revisions that are purely financially motivated and not relevant to the matter in hand. CSS considers tariff autonomy and a functioning tariff partnership to be an important element of competition and supports every effort to find a solution to the negotiations, while also supporting subsidiary interventions by the Federal Council if tariff autonomy fails to lead to a solution that is both fit for purpose and acceptable to the premium payers.